• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tevogen Inc. - Warrant (NQ:TVGNW)

    0.0605 -0.0090 (-12.95%)
    Delayed Quote Updated: 3:59 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 269,982
    Open 0.0685
    Bid (Size) 0.0604 (1,500)
    Ask (Size) 0.0669 (1,000)
    Prev. Close 0.0695
    Today's Range 0.0604 - 0.0730
    52wk Range 0.0253 - 0.0750
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
    Both previously disclosed Nasdaq compliance matters are now closed 
    From Tevogen Inc.
    Via GlobeNewswire
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill

    Performance

    YTD
    +44.4%
    +44.4%
    1 Month
    +21.0%
    +21.0%
    3 Month
    +34.4%
    +34.4%
    6 Month
    +99.0%
    +99.0%
    1 Year
    +9.0%
    +9.0%

    More News

    Read More
    News headline image
    Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
    From Tevogen Bio Inc
    Via GlobeNewswire
    Unusual volume stocks in Monday's session ↗
    Via Chartmill
    On Friday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Tevogen Bio Announces 2026 Annual Meeting of Stockholders
    From Tevogen Bio Inc
    Via GlobeNewswire
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    Top movers in Thursday's session ↗
    Via Chartmill
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Tevogen Announces Formation of a Healthcare Services Initiative
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
    From Tevogen Bio Inc
    Via GlobeNewswire
    Gapping stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Letter to Shareholders from CEO Dr. Ryan Saadi
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
    From Tevogen Bio Inc
    Via GlobeNewswire
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
    From Tevogen Bio Inc
    Via GlobeNewswire
    News headline image
    Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
    From Tevogen Bio Inc
    Via GlobeNewswire
    Top stock movements in today's session. ↗
    Via Chartmill
    Monday's session: top gainers and losers ↗
    Via Chartmill

    Frequently Asked Questions

    Is Tevogen Inc. - Warrant publicly traded?
    Yes, Tevogen Inc. - Warrant is publicly traded.
    What exchange does Tevogen Inc. - Warrant trade on?
    Tevogen Inc. - Warrant trades on the Nasdaq Stock Market
    What is the ticker symbol for Tevogen Inc. - Warrant?
    The ticker symbol for Tevogen Inc. - Warrant is TVGNW on the Nasdaq Stock Market
    What is the current price of Tevogen Inc. - Warrant?
    The current price of Tevogen Inc. - Warrant is 0.0605
    When was Tevogen Inc. - Warrant last traded?
    The last trade of Tevogen Inc. - Warrant was at 10/01/26 03:59 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.